FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula
, which can inhibit binding of protein Smac with apoptosis protein inhibitor (IAP).
EFFECT: improved properties of the inhibitor.
4 cl, 198 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER | 2007 |
|
RU2452492C2 |
| NOVEL TETRAZOLONE DERIVATIVES | 2014 |
|
RU2664644C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| PRODRUG 1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES | 2003 |
|
RU2357962C2 |
| PYRROLTRIAZINE KINASE INHIBITORS | 2000 |
|
RU2331640C2 |
| CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
| PIPERIDINE ALKYL CARBAMATE DERIVATIVES, PRODUCTION THEREOF AND USE THEREOF AS FAAH ENZYME INHIBITORS | 2005 |
|
RU2384569C2 |
| CYCLIC INHIBITORS OF PROTEIN-TYROSINE KINASE | 2000 |
|
RU2312860C2 |
| HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S TRANSPORTATION INHIBITORS | 2005 |
|
RU2424239C2 |
| DERIVATIVES OF 2,6-QUINOLINYL AND 2,6-NAPHTHYL, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, THEIR USING AS VLA-4 INHIBITORS AND INTERMEDIATE COMPOUNDS | 2003 |
|
RU2315041C2 |
